Literature DB >> 19897746

Strain-dependent activation of NF-kappaB in the airway epithelium and its role in allergic airway inflammation.

John F Alcorn1, Karina Ckless, Amy L Brown, Amy S Guala, Jay K Kolls, Matthew E Poynter, Charles G Irvin, Albert van der Vliet, Yvonne M W Janssen-Heininger.   

Abstract

NF-kappaB activation in the airway epithelium has been established as a critical pathway in ovalbumin (Ova)-induced airway inflammation in BALB/c mice (Poynter ME, Cloots R, van Woerkom T, Butnor KJ, Vacek P, Taatjes DJ, Irvin CG, Janssen-Heininger YM. J Immunol 173: 7003-7009, 2004). BALB/c mice are susceptible to the development of allergic airway disease, whereas other strains of mice, such as C57BL/6, are considered more resistant. The goal of the present study was to determine the proximal signals required for NF-kappaB activation in the airway epithelium in allergic airway disease and to unravel whether these signals are strain-dependent. Our previous studies, conducted in the BALB/c mouse background, demonstrated that transgenic mice expressing a dominant-negative version of IkappaBalpha in the airway epithelium (CC10-IkappaBalpha(SR)) were protected from Ova-induced inflammation. In contrast to these earlier observations, we demonstrate here that CC10-IkappaBalpha(SR) transgenic mice on the C57BL/6 background were not protected from Ova-induced allergic airway inflammation. Consistent with this finding, Ova-induced nuclear localization of the RelA subunit of NF-kappaB was not observed in C57BL/6 mice, in contrast to the marked nuclear presence of RelA in BALB/c mice. Evaluation of cytokine profiles in bronchoalveolar lavage demonstrated elevated expression of TNF-alpha in BALB/c mice compared with C57BL/6 mice after an acute challenge with Ova. Finally, neutralization of TNF-alpha by a blocking antibody prevented nuclear localization of RelA in BALB/c mice after Ova challenge. These data suggest that the mechanism of response of the airway epithelium of immunized C57BL/6 mice to antigen challenge is fundamentally different from that of immunized BALB/c mice and highlight the potential importance of TNF-alpha in regulating epithelial NF-kappaB activation in allergic airway disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19897746      PMCID: PMC2806198          DOI: 10.1152/ajplung.00037.2009

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  54 in total

1.  Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease.

Authors:  Ida Ricciardelli; Keith J Lindley; Marco Londei; Sonia Quaratino
Journal:  Immunology       Date:  2008-04-16       Impact factor: 7.397

Review 2.  Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease.

Authors:  Gye Young Park; John W Christman
Journal:  Curr Drug Targets       Date:  2006-06       Impact factor: 3.465

3.  Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease.

Authors:  John F Alcorn; Lisa M Rinaldi; Elizabeth F Jaffe; Mirjam van Loon; Jason H T Bates; Yvonne M W Janssen-Heininger; Charles G Irvin
Journal:  Am J Respir Crit Care Med       Date:  2007-08-29       Impact factor: 21.405

4.  TNF downmodulates the function of human CD4+CD25hi T-regulatory cells.

Authors:  Xavier Valencia; Geoffrey Stephens; Raphaela Goldbach-Mansky; Mildred Wilson; Ethan M Shevach; Peter E Lipsky
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

5.  Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice.

Authors:  Susumu Nakae; Lien H Ho; Mang Yu; Rossella Monteforte; Motoyasu Iikura; Hajime Suto; Stephen J Galli
Journal:  J Allergy Clin Immunol       Date:  2007-05-07       Impact factor: 10.793

6.  Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment.

Authors:  Patricia López; Jesús Gómez; Catuxa Prado; Carmen Gutiérrez; Ana Suárez
Journal:  J Rheumatol       Date:  2008-06-15       Impact factor: 4.666

7.  Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response.

Authors:  Jeroen N Stoop; Andrea M Woltman; Paula J Biesta; Johannes G Kusters; Ernst J Kuipers; Harry L A Janssen; Renate G van der Molen
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

8.  Suppressor activity among CD4+,CD25++ T cells is discriminated by membrane-bound tumor necrosis factor alpha.

Authors:  Jun Wang; Henrike van Dongen; Hans Ulrich Scherer; Tom W J Huizinga; Rene E M Toes
Journal:  Arthritis Rheum       Date:  2008-06

9.  Attenuation of allergen-induced airway hyperresponsiveness is mediated by airway regulatory T cells.

Authors:  Jennifer T Burchell; Matthew E Wikstrom; Philip A Stumbles; Peter D Sly; Debra J Turner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-11-21       Impact factor: 5.464

10.  The functional insufficiency of human CD4+CD25 high T-regulatory cells in allergic asthma is subjected to TNF-alpha modulation.

Authors:  Y-L Lin; C-C Shieh; J-Y Wang
Journal:  Allergy       Date:  2008-01       Impact factor: 13.146

View more
  10 in total

1.  Inactivation of I kappaB-kinase-beta dependent genes in airway epithelium reduces tobacco smoke induced acute airway inflammation.

Authors:  Sang Yeub Lee; Marina Miller; Jae Youn Cho; Dae Jin Song; Michael Karin; David H Broide
Journal:  Int Immunopharmacol       Date:  2010-05-18       Impact factor: 4.932

2.  Modulation of NF-κB and hypoxia-inducible factor--1 by S-nitrosoglutathione does not alter allergic airway inflammation in mice.

Authors:  Nels Olson; David I Kasahara; Milena Hristova; Risa Bernstein; Yvonne Janssen-Heininger; Albert van der Vliet
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08-06       Impact factor: 6.914

3.  IL-22 is essential for lung epithelial repair following influenza infection.

Authors:  Derek A Pociask; Erich V Scheller; Sivanarayana Mandalapu; Kevin J McHugh; Richard I Enelow; Cheryl L Fattman; Jay K Kolls; John F Alcorn
Journal:  Am J Pathol       Date:  2013-03-11       Impact factor: 4.307

4.  The receptor for advanced glycation end products is a central mediator of asthma pathogenesis.

Authors:  Pavle S Milutinovic; John F Alcorn; Judson M Englert; Lauren T Crum; Tim D Oury
Journal:  Am J Pathol       Date:  2012-08-11       Impact factor: 4.307

5.  Characterization of a novel high-dose ovalbumin-induced murine model of allergic sinonasal inflammation.

Authors:  Michelle Mendiola; Anuj Tharakan; Mengfei Chen; Tomefa Asempa; Andrew P Lane; Murugappan Ramanathan
Journal:  Int Forum Allergy Rhinol       Date:  2016-04-05       Impact factor: 3.858

6.  Long-chain acyl-CoA dehydrogenase deficiency as a cause of pulmonary surfactant dysfunction.

Authors:  Eric S Goetzman; John F Alcorn; Sivakama S Bharathi; Radha Uppala; Kevin J McHugh; Beata Kosmider; Rimei Chen; Yi Y Zuo; Megan E Beck; Richard W McKinney; Helen Skilling; Kristen R Suhrie; Anuradha Karunanidhi; Renita Yeasted; Chikara Otsubo; Bryon Ellis; Yulia Y Tyurina; Valerian E Kagan; Rama K Mallampalli; Jerry Vockley
Journal:  J Biol Chem       Date:  2014-03-03       Impact factor: 5.157

7.  Airway Hyperresponsiveness and Inflammation: Causation, Correlation, or No Relation?

Authors:  Yvonne Mw Janssen-Heininger; Charles G Irvin; Erich V Scheller; Amy L Brown; Jay K Kolls; John F Alcorn
Journal:  J Allergy Ther       Date:  2012-01-26

8.  Protease-activated receptor-2 activation contributes to house dust mite-induced IgE responses in mice.

Authors:  Sijranke Post; Irene H Heijink; Arjen H Petersen; Harold G de Bruin; Antoon J M van Oosterhout; Martijn C Nawijn
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

9.  Exposure to lipopolysaccharide (LPS) reduces contractile response of small airways from GSTCD-/- mice.

Authors:  Bo Liu; Amanda P Henry; Sheyda Azimi; Suzanne Miller; Frank K Lee; Jane C Lee; Kelly Probert; Michael I Kotlikoff; Ian Sayers; Ian P Hall
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

10.  Competitive metabolism of L-arginine: arginase as a therapeutic target in asthma.

Authors:  Jennifer M Bratt; Amir A Zeki; Jerold A Last; Nicholas J Kenyon
Journal:  J Biomed Res       Date:  2011-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.